Home Current Issue Previous Issues Blogs Online First ASA Practice Parameters CME For Authors Journal Info
Skip Navigation LinksHome > September 2004 - Volume 101 - Issue 3 > Inhaled Anesthetic Enhancement of Amyloid-β Oligomerization...
Anesthesiology:
September 2004 - Volume 101 - Issue 3 - pp 703-709
Laboratory Investigations

Inhaled Anesthetic Enhancement of Amyloid-β Oligomerization and Cytotoxicity

Eckenhoff, Roderic G. M.D.*; Johansson, Jonas S. M.D., Ph.D.†; Wei, Huafeng M.D., Ph.D.‡; Carnini, Anna Ph.D.§; Kang, Baobin M.D.∥; Wei, Wenlin M.D.#; Pidikiti, Ravindernath M.D.**; Keller, Jason M. B.Sc.∥; Eckenhoff, Maryellen F. Ph.D.††

Collapse Box

Abstract

Background: The majority of surgical patients receive inhaled anesthetics, principally small haloalkanes and haloethers. Long-term cognitive problems occur in the elderly subsequent to anesthesia and surgery, and previous surgery might also be a risk factor for neurodegenerative disorders like Alzheimer and Parkinson disease. The authors hypothesize that inhaled anesthetics contribute to these effects through a durable enhancement of peptide oligomerization.
Methods: Light scattering, filtration assays, electron microscopy, fluorescence spectroscopy and size-exclusion chromatography was used to characterize the concentration-dependent effects of halothane, isoflurane, propofol, and ethanol on amyloid β peptide oligomerization. Pheochromocytoma cells were used to characterize cytotoxicity of amyloid oligomers with and without the above anesthetics.
Results: Halothane and isoflurane enhanced amyloid beta oligomerization rates and pheochromocytoma cytotoxicity in vitro through a preference for binding small oligomeric species. Ethanol and propofol inhibited oligomerization at low concentration but enhanced modestly at very high concentration. Neither ethanol nor propofol enhanced amyloid β toxicity in pheochromocytoma cells.
Conclusions: Inhaled anesthetics enhance oligomerization and cytotoxicity of Alzheimer disease-associated peptides. In addition to the possibility of a general mechanism for anesthetic neurotoxicity, these results call for further evaluation of the interaction between neurodegenerative disorders, dementia, and inhalational anesthesia.

© 2004 American Society of Anesthesiologists, Inc.

Publication of an advertisement in Anesthesiology Online does not constitute endorsement by the American Society of Anesthesiologists, Inc. or Lippincott Williams & Wilkins, Inc. of the product or service being advertised.
Login




Help

Forgot Password?